Peptika.
European medical platform

Prescribed peptides
Made in Europe.

The first European medical platform for peptide therapies. Prescribed by EU-licensed physicians. Compounded in GMP-certified pharmacies. Delivered to your door.

Regulatory framework
Directive 2001/83/EC
Article 5(1) · Magistral
Quality testing
Pasteur Hellénique
Independent lab testing
Manufacturing
EU-GMP Annex 1
Grade A/B cleanrooms
Cross-border
Directive 2011/24/EU
Recognised across EU/EEA
The problem

99% of peptides sold in Europe are not for human use.

Every peptide you can buy today on European websites is sold under the same clause: “For research use only. Not for human consumption.” Behind that disclaimer hides an unregulated market — Chinese-sourced compounds, untested for heavy metals or bacterial contamination, dispensed without a prescription, dosed by guesswork.

Peptika is built on the opposite principle. Every peptide is prescribed by a licensed European physician. Every batch is independently tested. Every preparation is traceable to a named patient under European pharmaceutical law.

Today

The grey market

  • Legal status“Research use only” — not for human use.
  • SourcingUnverified Chinese suppliers.
  • TestingPurity only, if any.
  • PrescriptionNone.
  • ManufacturingUnregulated.
  • Cold chainStandard shipping.
  • TraceabilityNone.
Peptika.

The safe option

  • Legal statusMagistral preparation under Article 5(1) of Directive 2001/83/EC.
  • SourcingGMP-qualified European fill-finish.
  • TestingSterility, endotoxin, identity, heavy metals, bioburden.
  • PrescriptionEU-licensed physician, patient-named.
  • ManufacturingEU-GMP Annex 1, Qualified Person release.
  • Cold chainPharma-validated 2–8 °C logistics.
  • TraceabilityBatch Certificate of Analysis with every order.
How it works

Four steps.

Every Peptika protocol begins with a medical consultation. We never compound, never ship, never dispense without a physician's signed prescription. The architecture is non-negotiable.

01
Clinical Intake

Clinical intake

A structured 15-minute consultation reviews your medical history, current medications and any contraindications. AI-assisted triage filters cases before any human review.

02
Physician Review

Physician review

An EU-licensed physician reviews your file, requests a video consultation if needed, and either prescribes an individualised protocol or declines. No charge if your file is declined.

03
Magistral Compounding

Magistral compounding

Fulfilled by a European pharmacy under § 13 AMG (Germany) or equivalent Dutch Manufacturing Authorisation. Each preparation is named to you. Every batch independently tested.

04
Cold-chain Delivery

Cold-chain delivery

Pharma-qualified 2–8 °C logistics to your address anywhere in the EU/EEA. Vials, sterile consumables, reconstitution guide and your batch Certificate of Analysis included.

Our doctors

Licensed doctors across the European Union.

Every prescription is signed by a doctor registered with their national medical chamber and operating under Directive 2005/36/EC on cross-border professional qualifications. No template prescriptions. No prescriptions without a real medical review.

Fig. · Network density · EU / EEA

Verified credentials

Each physician's national licence number and medical chamber registration are visible on your patient dashboard before any prescription is issued.

Right of refusal

Physicians may decline any request they consider clinically inappropriate. No protocol is compounded without medical validation. If your file is declined, your products are fully refunded — the €49 consultation fee covers the medical review.

Continuity of care

If your assigned physician is unavailable, a peer in the network with equivalent credentials reviews your file. Follow-up consultations are guaranteed within 72 hours.

Pricing

One transparent consultation.

You pay at checkout for your consultation and products. Nothing is compounded until your physician validates a clinical indication, and any item they decline is fully refunded.

Initial consultationFixed fee
€49 · One-time

A flat consultation fee covering the full clinical intake and physician review. It covers the medical work and is not refundable; products are refunded if no clinical indication is identified.

  • Structured clinical questionnaire (15 min)
  • File review by an EU-licensed physician (within 48 h)
  • Optional video consultation if required
  • Summary prepared for your physician
  • Written quote before any compounding
Treatment protocolVariable
From €20 One-time or /month
Variable based on prescription

Monthly cost depends on the peptides prescribed, dosage, treatment duration and follow-up frequency. Your physician provides a transparent written quote before any preparation is compounded. You are free to decline or modify the proposal at any stage.

Indicative protocol ranges
  • Discovery
    Single-peptide therapy · annual follow-up
    €20 – €80
  • Core
    2–3 peptide protocol · quarterly follow-up
    €100 – €240
  • Premium
    4–5 peptides · monthly follow-up · biannual blood panel
    €200 – €440
  • Weight management
    GLP-1–based titration protocol
    €50 – €525

All quotes include compounding, pharmacopoeial-grade batch testing, cold-chain delivery and physician follow-up. An optional monthly renewal is available — 10% off every order, cancel anytime. Nothing recurring is charged before your written approval.

Quality

Every batch independently tested.

Each compounded preparation undergoes pharmacopoeial-grade quality testing before release. Certificates are signed off by qualified persons under EU-GMP Annex 1 and uploaded to your patient dashboard the moment they are issued.

Every certificate of analysis is downloadable directly from your patient dashboard. Batch numbers on your vials match the certificates in your account — full traceability, on demand.

FAQ

Clarity, before consultation.

How is Peptika different from peptides sold online today?+
Every peptide currently sold in Europe online operates under the “Research Use Only” clause — meaning it is sold legally only for laboratory research, not for human use. Peptika is the first European platform to deliver peptides under the legal magistral framework: each preparation is prescribed by an EU-licensed physician for a named patient, compounded in a GMP-certified European pharmacy, and dispensed under Article 5(1) of Directive 2001/83/EC. This is the same legal framework that allows pharmacies to prepare individualised medicines for hospital patients.
Who prescribes my protocol?+
A physician licensed and registered with the medical chamber of an EU/EEA member state. Their credentials are visible on your patient dashboard before any prescription is issued. They retain full clinical authority— including the right to decline a request — and operate independently of Peptika's commercial decisions.
Where are the peptides manufactured?+
In European compounding pharmacies operating under § 13 AMG (Germany) or equivalent Manufacturing Authorisation (Netherlands, Greece). Our manufacturing partners hold cleanrooms certified EU-GMP Annex 1 Grade A/B and employ Qualified Persons responsible for batch release under European pharmaceutical law.
Can I see the test results for my batch?+
Yes — the Certificate of Analysis for every batch you receive is uploaded to your patient dashboard automatically. The batch number on each vial corresponds to the certificate in your account.
Is this legal in my country?+
Peptika operates under EU directives that apply across all EU/EEA member states. Magistral preparations prescribed by an EU-licensed physician are recognised cross-border under Directive 2011/24/EU. We currently serve patients in the EU/EEA; if your country is not listed at checkout, please contact us before consultation.
What if my physician declines my request?+
Your products are fully refunded. The €49 consultation fee covers the medical review that was carried out and is not refunded. Your physician may also propose an alternative protocol or recommend additional medical follow-up before reconsidering the request.
Get started

A medical option for patients who refuse the grey market.

Fifteen minutes for the clinical questionnaire. Physician review within 48 hours. No charge if your file is declined.